-
PAIR GETS 12 YEARS FOR PONZI SCHEME
-
THE BARE BATTLE
-
Alleged assaults involved male cadet
-
After 30 years, U.S. to release Israeli spy
-
‘I jumped out and lunged at the bear’
-
NEXT GENERATION VACATION
-
CHOW RETURNS, BUT VICTORY FAR FROM ASSURED.
-
HUMAN KINDNESS
-
DEFLATING DAY
-
COMPLICATED CONFLICT
-
Why the West needs Turkey.
-
Unaware of big cat’s status, U.S. hunter says
-
Creature on the loose has city on edge
-
‘I MUST BE DEAD’
-
Ombudsman urges redress for victims
-
Why can’t I vote? asks Donald Sutherland
-
Scientists falsified data, report alleges
-
Canadian Milk Matters
-
Worker tells of smuggled tools, oral sex
-
On the Olympics, tread with caution
-
A sub-optimal deal
-
Little faith in God, politics or religions of peace
-
The Kinsey approach
-
The Senate matters
-
For want of a good speech
-
Yacht club reborn as ‘Spoke on the water’
-
Olympic bids can’t be rushed
-
Ready for the red carpet, Toronto’s film fest is coming soon.
-
Offence lags again and injuries remove two Jays
-
Blue Jays going for it, budget and all
-
Rugby squad pins hopes on more games
-
Phillies unload their closer to Nationals
-
Getting ‘the best shortstop’ too good to pass up
-
Hope and optimism as Maccabi Games get underway
-
Red carpet rollout
-
The elegance of Robin Phillips
-
CANADIAN CRISSCROSS
-
Mongolian Music mi x
-
Lost in interpretation
-
Detroit gives leg up to Canadian government’s bridge rival
-
ND P taxes bite into oilpatch
-
Renting rooms now helps get a mortgage
-
Oil pain fuels a dynasty feud
-
social climbers
-
Miner details
-
peter foster …
-
Obama will reject Keystone XL, senator says
-
Home Capital stock sinks ahead of key earnings call
-
When ETFs, funds get the axe
-
Refining the art of kissing up
-
Upstart phone maker taking run at the top
-
Ford profits surge on sales of F-150 trucks
-
Greek stock market on course to reopen
-
Spell out details on mining exploration
-
Facial-recognition tool raises red flags in U.S.
-
Amazon to help sell crowdfund products
-
Twitter shares rise on strong Q2 sales
-
Taking a global view of Canadian investing
-
Amgen may not be the next biotech
takeover target, analyst says
-
U.S. trading revenues may provide a sign of caution for Canadian banks
-
Whistleblower bounty risks
-
Clinton’s dumb tax plan
-
Cautionary tale cuts a wide swath